Most cited papers from Hope Foundation

Hope Foundation

What are the most cited papers from Hope Foundation?

The most cited paper from Hope Foundation is "Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial" (Kohei Shitara et al., 2018), with 532 citations. Next come "Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial" (488) and "Do unto others or treat yourself? The effects of prosocial and self-focused behavior on psychological flourishing." (359).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 27 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial Kohei Shitara et al. · The Lancet Oncology	21 Oct 2018	532
2	Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial Frank A. Vicini et al. · The Lancet Open access	Dec 2019	488
3	Do unto others or treat yourself? The effects of prosocial and self-focused behavior on psychological flourishing. S. Katherine Nelson, Kristin Layous, Steve W. Cole et al. · Emotion Open access	21 Apr 2016	359
4	Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate Peter A. Jezewski, A R Vieira, C Nishimura et al. · Journal of Medical Genetics Open access	Jun 2003	306
5	Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project Amit X. Garg et al. · Journal of the American Academy of Dermatology Open access	3 Jul 2019	290
6	Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children William J. Kimberling, Michael S. Hildebrand, Aiden Eliot Shearer et al. · Genetics in Medicine Open access	7 Jul 2010	275
7	Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial David A. Margolis, Cynthia C Brinson, Graham H.R. Smith et al. · The Lancet Infectious Diseases	19 Jul 2015	205
8	Social Regulation of Human Gene Expression Steve W. Cole · Current Directions in Psychological Science Open access	Jun 2009	196
9	Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain Deanna L. Kerrigan, Andrea R. Mantsios, Miguel Górgolas et al. · PLoS ONE Open access	5 Jan 2018	182
10	Kindness in the blood: A randomized controlled trial of the gene regulatory impact of prosocial behavior S. Katherine Nelson, Megan M. Fritz, Sonja Lyubomirsky et al. · Psychoneuroendocrinology Open access	31 Mar 2017	146
11	Qualitative Interviewing Using Interpersonal Process Recall: Investigating Internal Experiences during Professional-Client Conversations Denise J. Larsen, Keri Flesaker, Rachel Stege · International Journal of Qualitative Methods Open access	Mar 2008	131
12	Understanding the role of hope in counselling: Exploring the intentional uses of hope Denise J. Larsen, Wendy Edey, Lenora M. LeMay · Counselling Psychology Quarterly	Dec 2007	125
13	Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial Moti N. Ramgopal et al. · The Lancet HIV	8 Aug 2023	122
14	Barbiturates in focal ischemia of primate cortex: effects on blood flow distribution, evoked potential and extracellular potassium. Neil M. Branston, Daniel Hope, L. Symon · Stroke Open access	Nov 1979	108
15	Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta‐Analysis Aparna Wagle Shukla, Jonathan J. Shuster, Jae Woo Chung et al. · PM&R Open access	24 Aug 2015	95
16	The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer Verena Thewes et al. · Oncogene	20 Mar 2017	89
17	Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group Marin Strijker, Tara M. Mackay, Bert A. Bonsing et al. · Annals of Surgery Open access	21 Feb 2020	87
18	Maternal vitamin B‐6 and folate status and risk of oral cleft birth defects in the Philippines Ronald G. Munger, Howerde E. Sauberlich, Christopher D. Corcoran et al. · Birth Defects Research Part A Clinical and Molecular Teratology	25 Jun 2004	82
19	Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections Michael L. Corrado · Journal of Antimicrobial Chemotherapy Open access	Nov 2010	78
20	Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER) James A. Underberg, Christopher Paul Cannon, Dominique G. Larrey et al. · Journal of clinical lipidology Open access	19 Aug 2020	75
21	Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies Laura Ann Adang et al. · Molecular Genetics and Metabolism Open access	20 Aug 2017	74
22	Grandmother Dishonored: Violence Against Women by Male Partners in American Indian Communities Barbara Chester, Robert W. Robin, Mary P. Koss et al. · Violence and Victims	1994	69
23	Prevention of Postpartum Traumatic Stress in Mothers with Preterm Infants: Manual Development and Evaluation Richard John Shaw, Carrie J. Sweester, Nicholas St. John et al. · Issues in Mental Health Nursing Open access	Aug 2013	62
24	Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours Ying Zhou et al. · JAMA Open access	7 Aug 2025	61
25	Introducing Qigong Meditation into Residential Addiction Treatment: A Pilot Study Where Gender Makes a Difference Kevin W. Chen, Anthony W Comerford, Phillip Shinnick et al. · The Journal of Alternative and Complementary Medicine	22 Jul 2010	61
26	Plasma zinc concentrations of mothers and the risk of nonsyndromic oral clefts in their children: A case‐control study in the Philippines Tsunenobu Tamura, Ronald G. Munger, Christopher D. Corcoran et al. · Birth Defects Research Part A Clinical and Molecular Teratology	15 Aug 2005	59
27	Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial Ridhima Vij, Kevin A. Stebbings, Hosu Kim et al. · Stem Cell Research & Therapy Open access	3 Mar 2022	54
28	Client Accounts of Hope in Early Counseling Sessions: A Qualitative Study Denise J. Larsen, Rachel Stege · Journal of Counseling & Development	2012	51
29	Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial Rebecca Arielle Shatsky et al. · Nature Medicine Open access	14 Sep 2024	50
30	Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP) Edward Chiaming Hsiao et al. · British Journal of Clinical Pharmacology Open access	5 Oct 2018	50
31	Lost in limbo? Navigating (im)mobilities and practices of appropriation of non-deportable refugees in the Mediterranean area Sarah Nimführ, Buba Sesay · Comparative Migration Studies Open access	27 Jun 2019	49
32	Consensus statement on preventive and symptomatic care of leukodystrophy patients Keith P. van Haren, Joshua L. Bonkowsky, Geneviève Bernard et al. · Molecular Genetics and Metabolism	27 Dec 2014	48
33	LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design Dirk Jacobus Blom, Zahi A. Fayad, John J.P. Kastelein et al. · Journal of clinical lipidology Open access	Dec 2015	47
34	Heparin in the treatment of chronic obstructive bronchopulmonary disease Joseph P. Boyle, Reginald H. Smart, John K. Shirey · The American Journal of Cardiology	Jul 1964	47
35	Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease Subha Karumuthil‐Melethil, Sahana Nagabhushan Kalburgi, Patrick Thompson et al. · Human Gene Therapy Open access	19 May 2016	44
36	Circles of Care Laura C. Hanson, Tonya D. Armstrong, Melissa A. Green et al. · Health Education & Behavior Open access	16 Oct 2012	42
37	Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II Linnea Thorlacius et al. · British Journal of Dermatology Open access	28 Oct 2017	41
38	Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-Experienced Patients in TITAN Dénes Bánhegyi, Christine Katlama, Clóvis Arns da Cunha et al. · Current HIV Research	Mar 2012	41
39	Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event Neha Shukla, Maia Paul, Meghan C. Halley et al. · British Journal of Dermatology Open access	28 Dec 2019	40
40	Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery Jill Wood, Lori Sames, Allison T. Moore et al. · Drug Discovery Today	19 Aug 2013	40
41	Use of Low-Titer O-Positive Whole Blood in Female Trauma Patients: A Literature Review, Qualitative Multidisciplinary Analysis of Risk/Benefit, and Guidelines for Its Use as a Universal Product in Hemorrhagic Shock Thomas West Clements, Jan‐Michael Van Gent, Neethu Menon et al. · Journal of the American College of Surgeons	6 Nov 2023	38
42	Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects G M2 Gangliosidosis in Sandhoff Mice Karlaina J.L. Osmon, Evan Woodley, Patrick Thompson et al. · Human Gene Therapy	19 May 2016	37
43	The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in Neonates Courtney J. Wusthoff, Adam L. Numis, Ronit Pressler et al. · Journal of Clinical Neurophysiology	9 Oct 2024	36
44	Compared DNA and RNA quality of breast cancer biobanking samples after long-term storage protocols in − 80 °C and liquid nitrogen Maximilian Babel, Andreas Mamilos, Stephan Seitz et al. · Scientific Reports Open access	Sep 2020	36
45	Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 Joseph J. Eron et al. · Antiviral Research Open access119 authors	4 Jul 2019	36
46	Assessing the impact of the Indian Ocean tsunami on households: a modified domestic assets index approach Sudha Arlikatti, Walter Gillis Peacock, Carla S. Prater et al. · Disasters	8 Mar 2010	35
47	Supporting families in their child's journey with neonatal encephalopathy and therapeutic hypothermia Betsy Pilon, Alexa Kanwit Craig, Monica E. Lemmon et al. · Seminars in Fetal and Neonatal Medicine Open access	16 Sep 2021	33
48	Pain Coping Skills Training for Patients Receiving Hemodialysis Laura M. Dember et al. · JAMA Internal Medicine Open access202 authors	30 Dec 2024	32
49	Reflections on 50 Years of Newborn Screening Coleen A. Boyle, Joseph A. Bocchini, James G. Kelly · PEDIATRICS Open access	20 May 2014	31
50	Working with refugee survivors of torture. Barbara Chester, Neal Holtan · PubMed Open access	Sep 1992	31

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.